InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.06
(
-0.52%
)
Bitcoin
54,975.76
(
-1.56%
)
Post# of 27676
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

badshah

Send PM Follow Ignore
Followers 58
Posts 1369
Boards Moderated 0
Alias Born 01/15/2007

badshah

Re: biotechzeek post# 9598

Wednesday, 12/30/2015 5:26:56 AM

Wednesday, December 30, 2015 5:26:56 AM

Post# of 27676
"This approval gives the Company an immediate go ahead to start patient enrollment for a Phase 1/2 study using Rich Pharmaceuticals' lead compound RP-323 in clinical trials."

This does not look like a safety trial ???? actual humans to be involved ???
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up